Okkenhaug K - Search Results

1

PI3Ks in lymphocyte signaling and development.

Okkenhaug K, Fruman DA. Okkenhaug K, et al. Curr Top Microbiol Immunol. 2010;346:57-85. doi: 10.1007/82_2010_45. Curr Top Microbiol Immunol. 2010. PMID: 20563708 Free PMC article. Review.

2

Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release.

Stewart H, Palmulli R, Johansen KH, McGovern N, Shehata OM, Carnell GW, Jackson HK, Lee JS, Brown JC, Burgoyne T, Heeney JL, Okkenhaug K, Firth AE, Peden AA, Edgar JR. Stewart H, et al. Among authors: okkenhaug k. EMBO Rep. 2023 Dec 6;24(12):e57224. doi: 10.15252/embr.202357224. Epub 2023 Oct 11. EMBO Rep. 2023. PMID: 37818801 Free PMC article.

3

PI3K in lymphocyte development, differentiation and activation.

Okkenhaug K, Vanhaesebroeck B. Okkenhaug K, et al. Nat Rev Immunol. 2003 Apr;3(4):317-30. doi: 10.1038/nri1056. Nat Rev Immunol. 2003. PMID: 12669022 Review.

4

The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells.

Okkenhaug K, Patton DT, Bilancio A, Garçon F, Rowan WC, Vanhaesebroeck B. Okkenhaug K, et al. J Immunol. 2006 Oct 15;177(8):5122-8. doi: 10.4049/jimmunol.177.8.5122. J Immunol. 2006. PMID: 17015696

5

Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells.

Patton DT, Garden OA, Pearce WP, Clough LE, Monk CR, Leung E, Rowan WC, Sancho S, Walker LS, Vanhaesebroeck B, Okkenhaug K. Patton DT, et al. Among authors: okkenhaug k. J Immunol. 2006 Nov 15;177(10):6598-602. doi: 10.4049/jimmunol.177.10.6598. J Immunol. 2006. PMID: 17082571

6

Antigen receptor signalling: a distinctive role for the p110delta isoform of PI3K.

Okkenhaug K, Ali K, Vanhaesebroeck B. Okkenhaug K, et al. Trends Immunol. 2007 Feb;28(2):80-7. doi: 10.1016/j.it.2006.12.007. Epub 2007 Jan 5. Trends Immunol. 2007. PMID: 17208518 Free PMC article. Review.

7

The PI3K p110delta controls T-cell development, differentiation and regulation.

Patton DT, Garçon F, Okkenhaug K. Patton DT, et al. Among authors: okkenhaug k. Biochem Soc Trans. 2007 Apr;35(Pt 2):167-71. doi: 10.1042/BST0350167. Biochem Soc Trans. 2007. PMID: 17371229 Review.

8

p110delta is required for innate immunity to transplantable lymphomas.

Saudemont A, Okkenhaug K, Colucci F. Saudemont A, et al. Among authors: okkenhaug k. Biochem Soc Trans. 2007 Apr;35(Pt 2):183-5. doi: 10.1042/BST0350183. Biochem Soc Trans. 2007. PMID: 17371233

9

Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking.

Sinclair LV, Finlay D, Feijoo C, Cornish GH, Gray A, Ager A, Okkenhaug K, Hagenbeek TJ, Spits H, Cantrell DA. Sinclair LV, et al. Among authors: okkenhaug k. Nat Immunol. 2008 May;9(5):513-21. doi: 10.1038/ni.1603. Epub 2008 Apr 6. Nat Immunol. 2008. PMID: 18391955 Free PMC article.

10

Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production.

Zhang TT, Okkenhaug K, Nashed BF, Puri KD, Knight ZA, Shokat KM, Vanhaesebroeck B, Marshall AJ. Zhang TT, et al. Among authors: okkenhaug k. J Allergy Clin Immunol. 2008 Oct;122(4):811-819.e2. doi: 10.1016/j.jaci.2008.08.008. J Allergy Clin Immunol. 2008. PMID: 19014771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page